Organon & Co. (OGN) is scheduled to release first-quarter 2024 results on May 2, before the opening bell. In the last reported quarter, the company’s earnings beat estimates by 10%. It delivered an average earnings surprise of 5.1% in the past four quarters. Q1 Estimates The Zacks Consensus Estimate for revenues is pegged at $1.57 billion. The consensus mark for earnings is pinned at 97 cents per share. Factors to Note Organon’s first quarter witnessed growth in the Women’s Health revenues on the back of st ...